[
    [
        {
            "time": "",
            "original_text": "科創板第五十四周交易大復盤：新鮮事有趣事創紀錄的事應有盡有",
            "features": {
                "keywords": [
                    "科創板",
                    "交易",
                    "復盤",
                    "新鮮事",
                    "有趣事",
                    "紀錄"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "科創板第五十四周交易大復盤：新鮮事有趣事創紀錄的事應有盡有",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "光伏產業仍具投資價值",
            "features": {
                "keywords": [
                    "光伏",
                    "產業",
                    "投資",
                    "價值"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "光伏產業仍具投資價值",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【平安生物】港股醫藥策略報告：優質標的集合，長期配置優選",
            "features": {
                "keywords": [
                    "平安生物",
                    "港股",
                    "醫藥",
                    "策略",
                    "報告",
                    "優質標的",
                    "長期配置"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【平安生物】港股醫藥策略報告：優質標的集合，長期配置優選",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "銷售領域複刻“燒錢模式” 百濟神州(06160)半年砸16億開闢新藥市場",
            "features": {
                "keywords": [
                    "銷售",
                    "燒錢模式",
                    "百濟神州",
                    "新藥市場"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "銷售領域複刻“燒錢模式” 百濟神州(06160)半年砸16億開闢新藥市場",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "粵開策略 | 大勢研判：震盪上行，關注四大主線（附中報最新解讀）",
            "features": {
                "keywords": [
                    "粵開策略",
                    "震盪上行",
                    "四大主線",
                    "中報解讀"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "綜合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粵開策略 | 大勢研判：震盪上行，關注四大主線（附中報最新解讀）",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飛生物：疫苗行業第一股總市值站上3000億估值是否已經泡沫化?",
            "features": {
                "keywords": [
                    "智飛生物",
                    "疫苗",
                    "行業",
                    "市值",
                    "泡沫化"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飛生物：疫苗行業第一股總市值站上3000億估值是否已經泡沫化?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]